MMG-11 is a toll-like receptor 2 (TLR2) antagonist that selectively blocks TLR2/1 over TLR2/6 heterodimer-mediated sginaling in both human & murine species (NF-κB/AP-1 activation IC50 = 0.87 µM vs. 7.4 µM in hTLR2/1 or hTLR2/6 HEK293 reporter cells stimulated with 10 ng/mL TLR2/1 agonist Pam3CSK4 or 1 ng/mL TLR2/6 agonist Pam2CSK4; TNF/IL-6 secretion IC50 = 3.3/0.19 µM against 10 ng/mL Pam3CSK4 vs. 58/14 µM against 1 ng/mL Pam2CSK4 using murine macrophage RAW 264.7). In contrast, the TLR2 antagonist CU-CPT22 is selective for hTLR2/6 over hTLR2/1, while being weakly selective for mTLR2/1 over mTLR2/6 heterodimer.
Toll-like receptor 2 (TLR2) antagonist that selectively blocks TLR2/1 over TLR2/6 heterodimer-mediated sginaling in both human & murine species.
Toll-like receptor 2 (TLR2) forms heterodimers with either TLR1 or TLR6 to induce protective early inflammatory responses to pathogen- and damage-associated molecular patterns. However, excessive activation is associated with inflammatory and metabolic diseases. Several TLR2 antagonists have been described but
Questions
Reviews
★★★★★ No rating value
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.